Imricor Medical Systems
Minneapolis
About Imricor Medical Systems
Imricor Medical Systems develops magnetic resonance imaging (MRI) compatible electrophysiology tools for the treatment of cardiac arrhythmias. The company offers Vision MR EP Ablation Catheter that looks and performs as a conventional ablation catheter; and Horizon MR EP Recording System, which performs the recording and pacing function of conventional recording and pacing systems for use with MRI. Its products allow electrophysiologists to perform cardiac electrophysiology procedures in the MRI lab to image a patient's heart.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2023)
- Ticker: asx:IMR
- Website: imricor.com
- Phone: 952-818-8400
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/imricor-medical-systems-72695 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.